Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website https://www.jocmr.org

Original Article

Volume 15, Number 2, February 2023, pages 99-108


Cannabis Use and Its Association With Thirty- and Ninety-Day Hospital Readmissions for Patients Admitted for an Inflammatory Bowel Disease Exacerbation

Figure

Figure 1.
Figure 1. Cannabis use classifications.

Tables

Table 1. Demographic and Patient Characteristics (N = 1,021)
 
CCI: Charlson comorbidity index; IBD: inflammatory bowel disease; LOS: length of stay; SD: standard deviation.
Age (years)
  Mean (SD)45.28 (20.24)
Gender
  Female542 (53.09)
  Male479 (46.91)
Race
  African American/Black150 (14.69)
  Asian54 (5.29)
  Other/multiracial143 (14.01)
  White674 (66.01)
Cannabis use
  Yes74 (7.25)
  No947 (92.75)
Hospital opioid use
  Yes322 (31.54)
  No699 (68.46)
Tobacco use
  Current100 (9.79)
  Former172 (16.85)
  Never617 (60.43)
  Unknown132 (12.93)
Alcohol use
  Current179 (17.53)
  Former24 (2.35)
  Never408 (39.96)
  Unknown410 (40.16)
IBD type
  Crohn’s disease484 (47.40)
  Ulcerative colitis537 (52.60)
CCI
  Mean (SD)2.17 (2.88)
LOS (days)
  Mean (SD)6.39 (7.11)

 

Table 2. Association Between Pre-Admission Characteristics and Cannabis Use (N = 1,021)
 
Cannabis use (n = 74), n (%)No cannabis use (n = 947), n (%)Univariable OR (95% CI)P-valueMultivariable OR (95% CI)P-value
CCI: Charlson comorbidity index; CI: confidence interval; IBD: inflammatory bowel disease; OR: odds ratio; SD: standard deviation.
Patient characteristics
  Age (years)
    Mean (SD)36.46 (15.52)45.97 (20.41)0.97 (0.96 - 0.99)0.00010.96 (0.94 - 0.98)< 0.0001
  Gender
    Female22 (29.73)520 (54.91)0.35 (0.21 - 0.58)< 0.00010.28 (0.16 - 0.50)< 0.0001
    Male52 (70.27)427 (45.09)ReferenceReference
  Race
    African American/Black21 (28.38)129 (13.62)2.51 (1.44 - 4.40)0.00122.80 (1.50 - 5.23)0.0012
    Asian3 (4.05)51 (5.39)0.90 (0.27 - 3.04)0.87571.12 (0.31 - 3.96)0.8667
    Other/multiracial9 (12.16)134 (14.15)1.04 (0.49 - 2.19)0.92401.11 (0.50 - 2.48)0.7978
    White41 (55.41)633 (66.84)ReferenceReference
  Tobacco use
    Current17 (22.97)83 (8.76)3.32 (1.78 - 6.16)0.00022.97 (1.48 - 6.02)0.0022
    Former12 (16.22)160 (16.90)1.21 (0.61 - 2.38)0.58001.70 (0.78 - 3.71)0.1788
    Never36 (48.65)581 (61.35)ReferenceReference
    Unknown9 (12.16)123 (12.99)1.19 (0.55 - 2.52)0.66641.26 (0.50 - 3.16)0.6319
  Alcohol use
    Current17 (22.97)162 (17.11)1.32 (0.71 - 2.47)0.37941.04 (0.53 - 2.07)0.8998
    Former6 (8.11)18 (1.90)4.22 (1.55 - 11.38)0.00473.71 (1.20 - 11.36)0.0227
    Never30 (40.54)378 (39.92)ReferenceReference
    Unknown21 (28.38)389 (41.08)0.68 (0.38 - 1.21)0.18920.51 (0.25 - 1.04)0.0644
Clinical characteristics
  Anxiety
    Yes14 (18.92)91 (9.61)2.20 (1.18 - 4.09)0.01302.72 (1.30 - 5.70)0.0080
    No60 (81.08)856 (90.39)ReferenceReference
  Depression
    Yes12 (16.22)53 (5.60)3.25 (1.66 - 6.43)0.00063.97 (1.78 - 8.87)0.0007
    No62 (83.78)894 (94.40)ReferenceReference
  IBD type
    Crohn’s disease42 (56.76)442 (46.67)1.51 (0.93 - 2.42)0.0961--
    Ulcerative colitis32 (43.24)505 (53.33)Reference--
  CCI
    Mean (SD)1.35 (2.35)2.23 (2.90)0.87 (0.78 - 0.97)0.0124--

 

Table 3. Association Between Cannabis Use and Hospital Opioid Use With 30-Day Readmission Among Patients With Crohn’s Disease (N = 484)
 
Yes (n = 92), n (%)No (n = 392), n (%)Univariable OR (95% CI)P-valueMultivariable OR (95% CI)P-value
aOdds ratio was not computed for former alcohol users due to low cell counts. CCI: Charlson comorbidity index; CI: confidence interval; LOS: length of stay; OR: odds ratio; SD: standard deviation.
Main exposures
  Cannabis use
    Yes5 (5.43)37 (9.44)0.55 (0.21 - 1.45)0.22560.59 (0.22 - 1.62)0.3079
    No87 (94.57)355 (90.56)ReferenceReference
  Hospital opioid use
    Yes39 (42.39)132 (33.67)1.45 (0.91 - 2.31)0.11661.45 (0.89 - 2.33)0.1343
    No53 (57.61)260 (66.33)ReferenceReference
Patient characteristics
  Age (years)
    Mean (SD)44.64 (19.12)44.34 (19.15)1.00 (0.99 - 1.01)0.8924--
  Gender
    Female48 (52.17)212 (54.08)0.92 (0.59 - 1.46)0.7412--
    Male44 (47.83)180 (45.92)Reference--
  Race
    African American/Black21 (22.83)64 (16.33)1.68 (0.95 - 3.01)0.07311.99 (1.08 - 3.67)0.0261
    Asian4 (4.35)13 (3.32)1.58 (0.50 - 5.06)0.43602.12 (0.65 - 6.93)0.2116
    Other/multiracial14 (15.22)42 (10.71)1.72 (0.87 - 3.37)0.11522.01 (1.00 - 4.04)0.0484
    White53 (57.61)273 (69.64)Reference
  Tobacco use
    Current12 (13.04)47 (11.99)1.14 (0.57 - 2.30)0.7144--
    Former17 (18.48)53 (13.52)1.43 (0.77 - 2.67)0.2575--
    Never54 (58.70)241 (61.48)Reference--
    Unknown9 (9.78)51 (13.01)0.79 (0.36 - 1.70)0.5421--
  Alcohol use
    Current13 (14.13)71 (18.11)0.76 (0.38 - 1.53)0.4486--
    Formera0 (0.00)6 (1.53)NANA--
    Never38 (41.30)159 (40.56)Reference--
    Unknown41 (44.57)156 (39.80)1.11 (0.67 - 1.80)0.7059--
Clinical characteristics
  Anxiety
    Yes11 (11.96)47 (11.99)1.00 (0.49 - 2.01)0.9929--
    No81 (88.04)345 (88.01)Reference--
  Depression
    Yes3 (3.26)33 (8.42)0.37 (0.11 - 1.23)0.10240.35 (0.10 - 1.22)0.0995
    No89 (96.74)359 (91.58)Reference
  CCI
    Mean (SD)2.79 (3.59)1.86 (2.40)1.12 (1.11 - 1.23)0.10241.15 (1.07 - 1.25)0.0005
  LOS (days)
    Mean (SD)7.28 (6.33)5.62 (7.70)1.02 (1.00 - 1.05)0.0790--

 

Table 4. Association Between Cannabis Use and Hospital Opioid Use With 30-Day Readmission Among Patients With Ulcerative Colitis (N = 537)
 
Yes (n = 92), n (%)No (n = 445), n (%)Univariable OR (95% CI)P-valueMultivariable OR (95% CI)P-value
CCI: Charlson comorbidity index; CI: confidence interval; LOS: length of stay; OR: odds ratio; SD: standard deviation.
Main exposures
  Cannabis use
    Yes10 (10.87)22 (4.94)2.34 (1.07 - 5.14)0.03312.48 (1.06 - 5.79)0.0363
    No82 (89.13)423 (95.06)ReferenceReference
  Hospital opioid use
    Yes26 (28.26)125 (28.09)1.01 (0.61 - 1.66)0.97350.79 (0.46 - 1.36)0.3958
    No66 (71.74)320 (71.91)ReferenceReference
Patient characteristics
  Age (years)
    Mean (SD)48.80 (22.15)45.50 (20.97)1.01 (1.00 - 1.02)0.1740--
  Gender
    Female49 (53.26)233 (52.36)1.04 (0.66 - 1.63)0.8748--
    Male43 (46.74)212 (47.64)Reference--
  Race
    African American/Black7 (7.61)58 (13.03)0.47 (0.21 - 1.08)0.07400.39 (0.16 - 0.95)0.0369
    Asian5 (5.43)32 (7.19)0.61 (0.23 - 1.62)0.32120.57 (0.21 - 1.55)0.2698
    Other/multiracial9 (9.78)78 (17.53)0.45 (0.21 - 0.94)0.03390.38 (0.18 - 0.84)0.0163
    White71 (77.17)277 (62.25)ReferenceReference
  Tobacco use
    Current5 (5.43)36 (8.09)0.77 (0.29 - 2.07)0.6094--
    Former23 (25.00)79 (17.75)1.62 (0.93 - 2.83)0.0877--
    Never49 (53.26)273 (61.35)Reference--
    Unknown15 (16.30)57 (12.81)1.46 (0.77 - 2.80)0.2449--
  Alcohol use
    Current12 (13.04)83 (18.65)0.78 (0.38 - 1.59)0.4926--
    Former6 (6.52)12 (2.70)2.69 (0.94 - 7.71)0.0635--
    Never33 (35.87)178 (40.00)Reference--
    Unknown41 (44.57)172 (38.65)1.28 (0.78 - 2.13)0.3283--
Clinical characteristics
  Anxiety
    Yes7 (7.61)40 (8.99)0.84 (0.36 - 1.93)0.6702--
    No85 (92.39)405 (91.01)Reference--
  Depression
    Yes5 (5.43)24 (5.39)1.01 (0.37 - 2.72)0.9872--
    No87 (94.57)421 (94.61)Reference--
  CCI
    Mean (SD)2.99 (3.43)2.14 (2.93)1.08 (1.02 - 1.16)0.0154--
  LOS (days)
    Mean (SD)10.03 (9.77)6.14 (5.71)1.07 (1.04 - 1.10)< 0.00011.07 (1.04 - 1.11)< 0.0001

 

Table 5. Association Between Cannabis Use and Hospital Opioid Use With 90-Day Readmission (N = 1,021)
 
Yes (n = 271), n (%)No (n = 750), n (%)Univariable OR (95% CI)P-valueMultivariable OR (95% CI)P-value
CCI: Charlson comorbidity index; CI: confidence interval; IBD: inflammatory bowel disease; LOS: length of stay; OR: odds ratio; SD: standard deviation.
Main exposures
  Cannabis use
    Yes21 (7.75)53 (7.07)1.11 (0.65 - 1.87)0.71051.19 (0.68 - 2.05)0.5537
    No250 (92.25)697 (92.93)ReferenceReference
  Hospital opioid use
    Yes92 (33.95)230 (30.67)1.16 (0.86 - 1.56)0.31921.01 (0.74 - 1.37)0.9742
    No179 (66.05)520 (69.33)ReferenceReference
Patient characteristics
  Age (years)
    Mean (SD)46.79 (20.43)44.73 (20.16)1.01 (1.00 - 1.01)0.15020.99 (0.98 - 1.00)0.0127
  Gender
    Female118 (43.54)361 (48.13)1.21 (0.91 - 1.59)0.19461.27 (0.95 - 1.70)0.1024
    Male153 (56.46)389 (51.87)Reference--
  Race
    African American/Black43 (15.87)107 (14.27)1.07 (0.72 - 1.58)0.7347--
    Asian12 (4.43)42 (5.60)0.76 (0.39 - 1.48)0.4195--
    Other/multiracial32 (11.81)111 (14.80)0.77 (0.50 - 1.18)0.2263--
    White184 (67.90)490 (65.33)Reference--
  Tobacco use
    Current32 (11.81)68 (9.07)1.42 (0.89 - 2.24)0.1376--
    Former54 (19.93)118 (15.73)1.38 (0.95 - 1.99)0.0910--
    Never154 (56.83)463 (61.73)Reference--
    Unknown31 (11.44)101 (13.47)0.92 (0.59 - 1.44)0.7215--
  Alcohol use
    Current38 (14.02)141 (18.80)0.70 (0.46 - 1.07)0.0998--
    Former7 (2.58)17 (2.27)1.07 (0.43 - 2.66)0.8758--
    Never113 (41.70)295 (39.33)Reference--
    Unknown113 (41.70)297 (39.60)0.99 (0.73 - 1.35)0.9655--
Clinical characteristics
  Anxiety
    Yes30 (11.07)75 (10.00)1.12 (0.72 - 1.75)0.6193--
    No241 (88.93)675 (90.00)Reference--
  Depression
    Yes17 (6.27)48 (6.40)0.98 (0.55 - 1.73)0.9415--
    No254 (93.73)702 (93.60)Reference--
  IBD type
    Crohn’s disease141 (52.03)343 (45.73)1.28 (0.97 - 1.70)0.07551.36 (1.02 - 1.81)0.0363
    Ulcerative colitis130 (47.97)407 (54.27)ReferenceReference
  CCI
    Mean (SD)2.80 (3.32)1.94 (2.66)1.11 (1.05 - 1.15)< 0.00011.16 (1.08 - 1.25)< 0.0001
  LOS (days)
    Mean (SD)8.10 (7.62)5.77 (6.82)1.04 (1.02 - 1.07)< 0.00011.04 (1.02 - 1.06)0.0002